Showing results (491-500 of 526) with videos related to

Sort By:
Pageof 53
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 21, 2021
Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patientAbeer N Alshukairi, Sherif A El-Kafrawy, Ashraf Dada, et al.
Oncoimmunology|January 12, 2023
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignanciesCamille Bigenwald, Yacine Haddad, Cassandra Thelemaque, et al.
Plos One|November 22, 2008
rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vectorIsabelle Magalhaes, Donata R Sizemore, Raija K Ahmed, et al.
Lancet (London, England)|May 27, 2014
Euro 2012 European Football Championship Finals: planning for a health legacyCatherine A H Smallwood, Katherine G Arbuthnott, Barbara Banczak-Mysiak, et al.
Frontiers in Immunology|July 19, 2023
Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohortJane Alexandra Shaw, Maynard Meiring, Candice Snyders, et al.
BMJ Global Health|October 8, 2020
Lockdown measures in response to COVID-19 in nine sub-Saharan African countriesNajmul Haider, Abdinasir Yusuf Osman, Audrey Gadzekpo, et al.
IJID Regions|June 20, 2022
Prognostic value of biochemical parameters among severe COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South AfricaAnnalise E Zemlin, Brian Allwood, Rajiv T Erasmus, et al.
The Lancet. Infectious Diseases|May 10, 2014
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trialSayoki G Mfinanga, Bruce J Kirenga, Duncan M Chanda, et al.
Journal of Medical Virology|September 25, 2020
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2Annalisa Mondi, Eleonora Cimini, Francesca Colavita, et al.
Vaccine|February 21, 2017
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trialsMaria Norrby, Timo Vesikari, Lars Lindqvist, et al.
Pageof 53